USPTO serial 73350076
Reviewed by CopyMark Law Group
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | PHARMACEUTICALS TAKEN ORALLY IN TABLET FORM FOR INCREASING MENTAL & PH YSICAL ENERGY, COMBATING INSOMNIA, LESSENING FATIGUE, IMPROVING CIRCUL ATION & MUSCLEPOWER, REDUCING PAIN FOR ARTERIOSCLEROTIC AND ARTHRITIC CONDITIONS, AND INHIBITING THE AGEING PROCESS | ABANDONED | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 6, 1984 | ABN1 | ABANDONMENT - EXPRESS MAILED | — |
| Mar 14, 1984 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 3, 1984 | CNSI | INQUIRY AS TO SUSPENSION MAILED | — |
| Apr 22, 1983 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 27, 1983 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 10, 1982 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 4, 1982 | DOCK | ASSIGNED TO EXAMINER | — |